Skip to content

Ketamine clinical trials: pipeline by phase and status

Every trial in this library's ClinicalTrials.gov slice that names Ketamine: 404 registered studies, grouped by phase and by recruitment status. For the published research, see the Ketamine research page.

The pipeline at a glance

By phase
PhaseTrials
Early phase 1 25
Phase 1 40
Phase 1/2 21
Phase 2 98
Phase 2/3 16
Phase 3 47
Phase 4 60
Not applicable 59
Unspecified 38
By status
StatusTrials
Recruiting or planned 91
Active, not recruiting 14
Completed 178
Stopped 67
Unknown or other 54

105,717 participants across the 403 trials that report enrollment. The earliest registered start is 2004, and 74 trials started in the last two years.

Most active sponsors

  • Yale University 26 trials
  • Janssen Research & Development, LLC 22 trials
  • Massachusetts General Hospital 14 trials
  • Icahn School of Medicine at Mount Sinai 9 trials
  • New York State Psychiatric Institute 7 trials

Evidence by condition

All 404 trials

Most advanced phase first, and within each phase the most recent start date first.

Phase 4 60 trials

Phase 3 47 trials

Phase 2/3 16 trials

Phase 2 98 trials

Phase 1/2 21 trials

Phase 1 40 trials

Early phase 1 25 trials

Not applicable 59 trials

Unspecified 38 trials

Data from ClinicalTrials.gov (opens in new tab), refreshed daily. Browse all clinical trials.